Log in

A novel Q93H missense mutation in DCTN1 caused distal hereditary motor neuropathy type 7B and Perry syndrome from a Chinese family

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The Dynactin 1 (DCTN1) encodes the p150 subunit of dynactin, which engages retrograde axonal transport. Missense mutations in DCTN1 have been linked to a series of neurodegenerative diseases, including distal hereditary motor neuropathies (dHMN) and Perry syndrome. A few pathogenic DCTN1 mutations related with Perry syndrome have been described within, or adjacent to, the highly conserved N-terminal cytoskeleton-associated protein, glycine-rich (CAP-Gly) domain. But to our best knowledge, only the pathogenic G59S mutation in DCTN1 has been reported in dHMN7B families. Herein, we provided a novel heterozygous mutation in DCTN1 which caused both dHMN7B and Perry syndrome from a Chinese family. Whole exome sequencing (WES) was performed to identify the disease-associated genes. Single nucleotide variants (SNVs) and small insertions/deletions (INDELs) were further predicted with Mutation Taster, Polymorphism Phenoty** v2 (PolyPhen-2), and Sorting Intolerant From Tolerant (SIFT) and compared to the Single Nucleotide Polymorphism Database(dbSNP), Exome Aggregation Consortium (ExAC), and the 1000 Genomes Project. Furthermore, a novel missense mutation c.279G>C (Q93H) in DCTN1 was identified as the candidate loci. The mutation was confirmed with Sanger sequencing in the family members and cosegregated with various phenotypes. In silico analysis and molecular structural modeling, the mutation not only caused the loss of a hydrogen bond within the p150 protein but also affected the formation of hydrogen bonds between p150 and EB. Therefore, the new Q93H mutation in DCTN1 caused both familial dHMN7B and Perry syndrome. Our findings could expand the clinical and pathogenic spectrum and strengthen the clinical diagnostic role of the DCTN1 gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Urnavicius L et al (2015) The structure of the dynactin complex and its interaction with dynein. Science 347(6229):1441–1446

    Article  CAS  Google Scholar 

  2. Cronin MA, Schwarz TL (2012) The CAP-Gly of p150: One domain, two diseases, and a function at the end. Neuron 74(2):211–213

    Article  CAS  Google Scholar 

  3. Honnappa S et al (2006) Key interaction modes of dynamic +TIP networks. Mol Cell 23(5):663–671

    Article  CAS  Google Scholar 

  4. Konno T et al (2017) DCTN1-related neurodegeneration: Perry syndrome and beyond. Parkinsonism Relat Disord 41:14–24

    Article  Google Scholar 

  5. Rossor AM et al (2012) The distal hereditary motor neuropathies. J Neurol Neurosurg Psychiatry 83(1):6–14

    Article  Google Scholar 

  6. Puls I et al (2003) Mutant dynactin in motor neuron disease. Nat Genet 33(4):455–456

    Article  CAS  Google Scholar 

  7. Hwang SH et al (2016) Distal hereditary motor neuropathy type 7B with Dynactin 1 mutation. Mol Med Rep 14(4):3362–3368

    Article  CAS  Google Scholar 

  8. Nam SH et al (2016) Identification of genetic causes of inherited peripheral neuropathies by targeted gene panel sequencing. Mol Cell 39(5):382–388

    Article  CAS  Google Scholar 

  9. Tian WT et al (2020) New phenotype of DCTN1-related spectrum: early-onset dHMN plus congenital foot deformity. Ann Clin Transl Neurol 7(2):200–209

    Article  CAS  Google Scholar 

  10. Chae JH et al (2015) Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders. J Med Genet 52(3):208–216

    Article  CAS  Google Scholar 

  11. Schabhüttl M et al (2014) Whole-exome sequencing in patients with inherited neuropathies: outcome and challenges. J Neurol 261(5):970–982

    Article  Google Scholar 

  12. Klein CJ et al (2014) Application of whole exome sequencing in undiagnosed inherited polyneuropathies. Journal of Neurology. Neurosurg Psychiatry 85(11):1265–1272

    Article  Google Scholar 

  13. Farrer MJ et al (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41(2):163–165

    Article  CAS  Google Scholar 

  14. Wider C et al (2010) Elucidating the genetics and pathology of Perry syndrome. J Neurol Sci 289(1–2):149–154

    Article  Google Scholar 

  15. Tsuboi Y et al (2008) Neurodegeneration involving putative respiratory neurons in Perry syndrome. Acta Neuropathol 115(2):263–268

    Article  Google Scholar 

  16. Wider C et al (2009) Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord 15(4):281–286

    Article  Google Scholar 

  17. Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424

    Article  Google Scholar 

  18. Schroer TA (2004) Dynactin. Annu Rev Cell Dev Biol 20(1):759–779

    Article  CAS  Google Scholar 

  19. Waterman-Storer CM, Karki S, Holzbaur EL (1995) The p150Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp-1). Proc Natl Acad Sci U S A 92(5):1634–1638

    Article  CAS  Google Scholar 

  20. Li Y, Garrett G, Zealear D (2017) Current treatment options for bilateral vocal fold paralysis: a state-of-the-art review. Clin Exp Otorhinolaryngol 10(3):203–212

    Article  CAS  Google Scholar 

  21. Araki E et al (2014) A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy. Mov Disord 29(9):1201–1204

    Article  CAS  Google Scholar 

  22. Tacik P et al (2014) Three families with Perry syndrome from distinct parts of the world. Parkinsonism Relat Disord 20(8):884–888

    Article  Google Scholar 

  23. Dixit R et al (2008) Regulation of dynactin through the differential expression of p150GluedIsoforms. J Biol Chem 283(48):33611–33619

    Article  CAS  Google Scholar 

  24. Stockmann M et al (2013) The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes. J Neural Transm (Vienna) 120(5):785–798

    Article  CAS  Google Scholar 

  25. Moughamian AJ, Holzbaur ELF (2012) Dynactin is required for transport initiation from the distal axon. Neuron 74(2):331–343

    Article  CAS  Google Scholar 

  26. Perry TL et al (1990) Dominantly inherited apathy, central hypoventilation, and Parkinson’s syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases. Neurology 40(12):1882–1887

    Article  CAS  Google Scholar 

  27. Cooper-Knock J et al (2017) Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype. Front Mol Neurosci 10:370

    Article  Google Scholar 

  28. Kuźma-Kozakiewicz M et al (2013) Dynactin deficiency in the CNS of humans with sporadic ALS and mice with genetically determined motor neuron degeneration. Neurochem Res 38:2463–2473

  29. Tanaka F et al (2012) Neuropathology and omics in motor neuron diseases. Neuropathology 32(4):458–462

    Article  Google Scholar 

  30. Bercier V et al (2019) Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Mol Neurodegener 14(1):27

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wei Zhang.

Ethics declarations

Ethical publication statement

We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this study is consistent with those guidelines.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures were approved by the Ethics committee of First Hospital of Shanxi Medical University (Taiyuan, China) and carried out in accordance with the principles of Helsinki Declaration.

Informed consent

Informed consent was preliminarily obtained from all patients and controls before their inclusion in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 2

(XLS 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Wang, H., Liu, W. et al. A novel Q93H missense mutation in DCTN1 caused distal hereditary motor neuropathy type 7B and Perry syndrome from a Chinese family. Neurol Sci 42, 3695–3705 (2021). https://doi.org/10.1007/s10072-020-04962-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04962-w

Keywords

Navigation